Versatope Therapeutics, Inc. logo

Versatope Therapeutics, Inc.

Versatope Therapeutics is using exosomes (extracellular vesicles) derived from genetically engineered probiotics as a technology platform for the targeted delivery of large molecules used in vaccines, therapeutics and diagnostics. These exosomes are nature’s liposome and can be delivered by injectable, mucosal and transdermal routes of administration.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.versatope.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
M2D2110 Canal St, MA 01852 UNITED STATES,,,United States
Lowell
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/versatope” connections=”true” suffix=””]